The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study is a Phase 2 Study to establish the safety and efficacy of a drug called Ivacaftor (VX-770) in patients with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and acquired CFTR dysfunction as detected by sweat chloride analysis. The design is a pilot, randomized (3:1, active:placebo), double-blind, placebo-controlled study. Approximately 40 subjects with COPD will be randomized.
Epistemonikos ID: 0c258005bb6fcfeb7868dcc3908d158430e1b240
First added on: May 20, 2024